Table 3.
A subgroup analysis of the severe OHSS rate.
Group 1 (n = 295) | Group 2 (n = 69) | OR (95% CI) | P-value | |||
---|---|---|---|---|---|---|
Total | Events (%) | Total | Events (%) | |||
bLH/FSH | ||||||
<1.33 | 161 | 4 (2.5) | 37 | 1 (2.7) | 1.09 (0.11–10.05) | 0.94 |
≥1.33 | 134 | 7 (5.2) | 32 | 7 (21.9) | 5.08 (1.64–15.76) | 0.005 |
AMH | ||||||
≤3.4 ng/ml | 20 | 1 (5.0) | 13 | 0 (0) | – | – |
>3.4 ng/ml | 275 | 10 (3.6) | 56 | 8 (14.3) | 4.42 (1.66–11.76) | 0.003 |
LH, luteinizing hormone; FSH, follicle-stimulating hormone; AMH, anti-Mullerian hormone; OR, odds ratio; CI, confidence interval.
Group 1 = “0”; group 2 = “1.”